News Posts List
Why Clinical Trials Matter: International Kidney Cancer Congress
12/19/2012
“We’ll hold the inaugural meeting of the recently formed International Kidney Cancer Congress in May, 2013, in Budapest, in concert with our International Kidney Cancer Symposium.”
Cytokine rise signals RCC progression
12/18/2012
Progression of renal cell carcinoma (RCC) is frequently preceded by a rise in levels of proangiogenic cytokines, Italian researchers have found.
Kidney Cancer Association Promotes Worldwide Awareness of Clinical Trials
12/18/2012
“For many patients, a clinical trial may be a reasonable option for treating advanced kidney cancer,” says Bill Bro, CEO of the US based Kidney Cancer Association (KCA).
Danish Translation of "We Have Kidney Cancer"
12/18/2012
Nyrekræft En praktisk vejledning til patienter og deres pårørende
VIDEO: Star Denise Richards and ShoeDazzle Support Kidney Cancer Research
12/18/2012
ShoeDazzle is pleased to announce its second annual partnership with actress and mother Denise Richards as part of its “Celebrity Shoe Design Program for Charity.” This year, Richards had someone special in mind to involve in the project as a shoe designer, Taylor “Tay” Filorimo.
Hard-to-treat Myc-driven Cancers May Be Susceptible to Drug Already Used in Clinic
12/18/2012
Drugs that are used in the clinic to treat some forms of breast and kidney cancer and that work by inhibiting the signaling molecule mTORC1 might have utility in treating some of the more than 15 percent of human cancers driven by alterations in the Myc gene, according to data from a preclinical study published in Cancer Discovery, a journal of the American Association for Cancer Research.
Denise Richards and ShoeDazzle Partner Again to Raise Funds for Kidney Cancer Association
12/18/2012
ShoeDazzle is pleased to announce its second annual partnership with actress and mother Denise Richards...
Partial nephrectomy maintains renal function in cT1a RCC
12/18/2012
Partial nephrectomy (PN) offers a similar magnitude of benefit in patients with clinical (c) T1b versus cT1a renal cell carcinoma (RCC), Japanese researchers have shown.
Nephron-sparing surgery beats ablation for small renal masses
12/18/2012
Nephron-sparing surgery (NSS) is more effective than ablation for the treatment of clinical stage T1a renal masses, research findings show.
Cancer Survivors: Words of Inspiration
12/18/2012
Surviving cancer is a different experience for everyone.
News Feed